Overview of Nomenclature of Nuclear Receptors
@article{Germain2006OverviewON, title={Overview of Nomenclature of Nuclear Receptors}, author={Pierre Germain and Bart Staels and Catherine Dacquet and Michael Spedding and Vincent Laudet}, journal={Pharmacological Reviews}, year={2006}, volume={58}, pages={685 - 704} }
Nuclear receptor pharmacology has, to a certain extent, led the way, compared with other receptor systems, in the appreciation that ligands may exert very diverse pharmacology, based on their individual chemical structure and the allosteric changes induced in the receptor/accessory protein complex. This can lead to very selective pharmacological effects, which may not necessarily be predicted from the experience with other agonists/partial agonists/antagonists. If this is the case, then drug…
637 Citations
Development of Nuclear Receptor Modulators.
- BiologyMethods in molecular biology
- 2018
Characteristics of nuclear receptors as target family, strategies of hit and lead identification, and the variety of methods for in vitro characterization of nuclear receptor modulators are summarized.
Resolution of controversies in drug/receptor interactions by protein structure. Limitations and pharmacological solutions
- BiologyNeuropharmacology
- 2011
Nuclear Receptors and Their Selective Pharmacologic Modulators
- Biology, ChemistryPharmacological Reviews
- 2013
The development and pharmacology of a range of selective nuclear receptor modulators are reviewed, where ligands display agonist/partial agonist-binding domain of nuclear receptors function in a tissue or gene selective manner.
A structural perspective on nuclear receptors as targets of environmental compounds
- Biology, ChemistryActa Pharmacologica Sinica
- 2015
A structural and mechanistic view of endocrine disrupting action using estrogen receptors α and β, (ERα/β), peroxisome proliferator activated receptor γ (PPARγ), and their respective environmental ligands as representative examples are provided.
Evolution of Nuclear Receptors and Ligand Signaling: Toward a Soft Key-Lock Model?
- BiologyCurrent topics in developmental biology
- 2017
IDPs and their complexes in GPCR and nuclear receptor signaling.
- BiologyProgress in molecular biology and translational science
- 2020
Alternative retinoid X receptor (RXR) ligands
- Biology, ChemistryMolecular and Cellular Endocrinology
- 2019
Therapeutic potential of nuclear receptors
- Biology, Medicine
- 2008
This review provides an overview on the molecular classification and disease relevance of NRs, as well as on recent advances in pharmacologic (pre-clinical targeting approaches and patent applications, using various databases and websites.
The Concise Guide to PHARMACOLOGY 2015/16: Nuclear hormone receptors
- BiologyBritish journal of pharmacology
- 2015
The Concise Guide to PHARMACOLOGY 2015/16 provides concise overviews of the key properties of over 1750 human drug targets with their pharmacology, plus links to an open access knowledgebase of drug…
Versatility or Promiscuity: The Estrogen Receptors, Control of Ligand Selectivity and an Update on Subtype Selective Ligands
- BiologyInternational journal of environmental research and public health
- 2014
How nature controls ER specificity and how the subtle differences in receptor subtypes are exploited in pharmaceutical design to achieve binding specificity and subtype selectivity for desired biological response are discussed.
References
SHOWING 1-10 OF 238 REFERENCES
Principles for modulation of the nuclear receptor superfamily
- Biology, ChemistryNature Reviews Drug Discovery
- 2004
This review provides a general overview of the mechanism of action of nuclear receptors and explores the various factors that are instrumental in modulating their pharmacology.
Coregulator function: a key to understanding tissue specificity of selective receptor modulators.
- BiologyEndocrine reviews
- 2004
Increased understanding of the effect of cellular environment on nuclear receptors and their coregulators has the potential to open the field of SRM discovery and research to many members of the nuclear receptor superfamily.
Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists.
- Biology, MedicineChemistry & biology
- 1999
Activation of nuclear receptors: a perspective from structural genomics.
- Biology, ChemistryStructure
- 2003
Molecular basis of agonism and antagonism in the oestrogen receptor
- Biology, ChemistryNature
- 1997
The crystal structures of the LBD of ER in complex with the endogenous oestrogen, 17β-oestradiol, and the selective antagonist raloxifene provide a molecular basis for the distinctive pharmacophore of the ER and its catholic binding properties.
Structural insights into the mode of action of a pure antiestrogen.
- Biology, ChemistryStructure
- 2001
Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications.
- Biology, ChemistryTrends in pharmacological sciences
- 2000